CCEL logo

Cryo-Cell International (CCEL) EBITDA

Annual EBITDA

-$10.42 M
-$17.07 M-256.65%

November 30, 2023

Summary

Performance

1-Year Change

-256.65%

3-Year Change

-244.3%

5-Year Change

-290.03%

15-Year Change

-302.03%

CCEL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.96%
CCEL annual EBITDA is higher than 63.96% of companies in Healthcare sector

High & Low

All-time High

$7.22 M
CCEL annual EBITDA is currently -244.30% below its historical high of $7.22 million

3-Year Low

-$10.42 M
CCEL annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Nov 30, 2023
CCEL previous annual earnings announcement was published on Nov 30, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CCEL next annual earnings announcement is scheduled for Feb 28, 2025

OtherCCELprofitabilitymetrics:

Annual Revenue

$31.34 M
CCEL annual revenue is $31.34 million

Annual Net Income

-$9.52 M
CCEL annual net profit is -$9.52 million

Annual EBIT

-$12.13 M
CCEL annual earnings before interest & taxes is -$12.13 million

Annual EPS

-$1.14
CCEL annual earnings per share is -$1.14

Quarterly EBITDA

$2.25 M
+$255.90 K+12.86%

August 1, 2024

Summary

Performance

3-Month Change

+12.86%

1-Year Change

+114.26%

3-Year Change

+114.26%

5-Year Change

+114.26%

CCEL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.67%
CCEL quarterly EBITDA is higher than 77.67% of companies in Healthcare sector

High & Low

All-time High

$2.46 M
CCEL quarterly EBITDA is currently -8.69% below its historical high of $2.46 million

3-Year Low

-$15.75 M

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELprofitabilitymetrics:

Quarterly Revenue

$8.07 M
CCEL quarterly revenue is $8.07 million

Quarterly Net Income

$1.05 M
CCEL quarterly net profit is $1.05 million

Quarterly EBIT

$1.91 M
CCEL quarterly earnings before interest & taxes is $1.91 million

Quarterly EPS

$0.13
CCEL quarterly earnings per share is $0.13

TTM EBITDA

-$10.30 M
+$288.50 K+2.72%

August 1, 2024

Summary

Performance

3-Month Change

+2.72%

1-Year Change

+1.08%

3-Year Change

+1.08%

5-Year Change

+1.08%

CCEL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.87%
CCEL TTM EBITDA is higher than 60.87% of companies in Healthcare sector

High & Low

All-time High

$8.20 M
CCEL TTM EBITDA is currently -225.74% below its historical high of $8.20 million

3-Year Low

-$11.34 M

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELprofitabilitymetrics:

TTM Revenue

$31.84 M
CCEL TTM revenue is $31.84 million

TTM Net Income

-$8.93 M
CCEL TTM net profit is -$8.93 million

TTM EBIT

-$11.40 M
CCEL TTM earnings before interest & taxes is -$11.40 million

TTM EPS

-$1.07
CCEL TTM earnings per share is -$1.07

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$10.42 M
CCEL annual EBITDA is -$10.42 million

Annual Net Income

-$9.52 M
CCEL annual net profit is -$9.52 million

Annual Interest Expense

$1.24 M
CCEL annual interest expense is $1.24 million

Annual Income Tax

-$3.84 M
CCEL annual income tax is -$3.84 million

Annual D&A

$1.71 M
CCEL annual depreciation & amortization is $1.71 million

CCEL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-256.6%+114.3%+1.1%
3 y3 years-244.3%+114.3%+1.1%
5 y5 years-290.0%+114.3%+1.1%

CCEL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-256.6%at lowat high+114.3%-247.7%+9.1%
5 y5-year-244.3%at low-8.7%+114.3%-225.7%+9.1%
alltimeall time-244.3%at low-8.7%+114.3%-225.7%+9.1%

Cryo-Cell International EBITDA History

DateAnnualQuarterlyTTM
Aug 2024
-
$2.25 M(+12.9%)
-$10.30 M(-2.7%)
May 2024
-
$1.99 M(+64.2%)
-$10.59 M(-6.5%)
Feb 2024
-
$1.21 M(-107.7%)
-$11.34 M(+8.8%)
Nov 2023
-$10.42 M(-256.6%)
-$15.75 M(-904.8%)
-$10.42 M(-249.3%)
Aug 2023
-
$1.96 M(+56.9%)
$6.98 M(+7.8%)
May 2023
-
$1.25 M(-41.4%)
$6.47 M(-5.4%)
Feb 2023
-
$2.13 M(+29.6%)
$6.85 M(+2.9%)
Nov 2022
$6.65 M(+25.1%)
$1.64 M(+13.1%)
$6.65 M(+45.0%)
Aug 2022
-
$1.45 M(-10.2%)
$4.59 M(-10.5%)
May 2022
-
$1.62 M(-16.4%)
$5.13 M(-12.8%)
Feb 2022
-
$1.93 M(-561.5%)
$5.88 M(+10.6%)
Nov 2021
$5.32 M(-26.4%)
-$419.20 K(-121.0%)
$5.32 M(-35.1%)
Aug 2021
-
$1.99 M(-15.9%)
$8.20 M(+7.3%)
May 2021
-
$2.37 M(+72.8%)
$7.64 M(+7.2%)
Feb 2021
-
$1.37 M(-44.2%)
$7.12 M(-1.3%)
Nov 2020
$7.22 M(+31.4%)
$2.46 M(+71.5%)
$7.22 M(+9.3%)
Aug 2020
-
$1.43 M(-22.8%)
$6.61 M(-9.5%)
May 2020
-
$1.86 M(+26.7%)
$7.30 M(+20.2%)
Feb 2020
-
$1.47 M(-20.6%)
$6.07 M(+10.5%)
Nov 2019
$5.50 M(+0.3%)
$1.85 M(-13.1%)
$5.50 M(-6.0%)
Aug 2019
-
$2.13 M(+236.1%)
$5.85 M(+22.5%)
May 2019
-
$632.30 K(-29.1%)
$4.77 M(-11.0%)
Feb 2019
-
$892.30 K(-59.4%)
$5.36 M(-2.2%)
Nov 2018
$5.48 M(+6.3%)
$2.20 M(+108.7%)
$5.48 M(+20.0%)
Aug 2018
-
$1.05 M(-13.7%)
$4.57 M(-9.2%)
May 2018
-
$1.22 M(+20.3%)
$5.03 M(+0.2%)
Feb 2018
-
$1.01 M(-21.0%)
$5.02 M(-2.6%)
Nov 2017
$5.16 M(-513.8%)
$1.28 M(-15.3%)
$5.16 M(+16.5%)
Aug 2017
-
$1.52 M(+25.2%)
$4.43 M(-1339.4%)
May 2017
-
$1.21 M(+5.5%)
-$357.20 K(+14.5%)
Feb 2017
-
$1.15 M(+107.0%)
-$311.90 K(-75.0%)
Nov 2016
-$1.25 M(-150.0%)
$554.30 K(-117.0%)
-$1.25 M(-36.1%)
Aug 2016
-
-$3.27 M(-360.4%)
-$1.95 M(-174.1%)
May 2016
-
$1.26 M(+489.4%)
$2.63 M(+29.2%)
Feb 2016
-
$213.00 K(-241.8%)
$2.04 M(-18.4%)
Nov 2015
$2.49 M(+13.1%)
-$150.20 K(-111.4%)
$2.49 M(-10.3%)
Aug 2015
-
$1.31 M(+98.8%)
$2.78 M(+30.3%)
May 2015
-
$660.30 K(-1.7%)
$2.13 M(+3.4%)
Feb 2015
-
$671.90 K(+398.1%)
$2.06 M(-6.5%)
Nov 2014
$2.21 M(+10.7%)
$134.90 K(-79.8%)
$2.21 M(-15.6%)
Aug 2014
-
$666.60 K(+13.1%)
$2.61 M(+0.8%)
May 2014
-
$589.60 K(-27.6%)
$2.59 M(+19.7%)
Feb 2014
-
$814.50 K(+50.3%)
$2.17 M(+8.7%)
Nov 2013
$1.99 M(-168.0%)
$541.90 K(-16.1%)
$1.99 M(+92.8%)
Aug 2013
-
$645.90 K(+297.0%)
$1.03 M(+429.9%)
May 2013
-
$162.70 K(-74.6%)
$195.00 K(-118.2%)
Feb 2013
-
$641.70 K(-253.9%)
-$1.07 M(-63.4%)
Nov 2012
-$2.93 M(-2693.9%)
-$416.90 K(+116.6%)
-$2.93 M(+35.2%)
Aug 2012
-
-$192.50 K(-82.6%)
-$2.17 M(-42.2%)
May 2012
-
-$1.11 M(-9.0%)
-$3.75 M(+98.1%)
Feb 2012
-
-$1.22 M(-451.0%)
-$1.89 M(-1441.5%)
Nov 2011
$113.00 K(-97.1%)
$346.30 K(-119.5%)
$141.10 K(-81.4%)
Aug 2011
-
-$1.77 M(-336.4%)
$758.00 K(-79.4%)
May 2011
-
$750.50 K(-8.3%)
$3.68 M(-5.3%)
Feb 2011
-
$818.50 K(-15.0%)
$3.89 M(-1.6%)
Nov 2010
$3.95 M
$963.20 K(-16.1%)
$3.95 M(+24.7%)
Aug 2010
-
$1.15 M(+20.0%)
$3.17 M(+4.1%)
DateAnnualQuarterlyTTM
May 2010
-
$956.70 K(+8.3%)
$3.05 M(-12.4%)
Feb 2010
-
$883.60 K(+387.4%)
$3.48 M(-5.4%)
Nov 2009
$3.63 M(+163.6%)
$181.30 K(-82.3%)
$3.68 M(-24.1%)
Aug 2009
-
$1.02 M(-26.3%)
$4.84 M(+24.1%)
May 2009
-
$1.39 M(+28.2%)
$3.90 M(+63.1%)
Feb 2009
-
$1.08 M(-19.6%)
$2.39 M(+80.7%)
Nov 2008
$1.38 M(-135.1%)
$1.35 M(+1508.2%)
$1.32 M(-212.3%)
Aug 2008
-
$83.70 K(-169.6%)
-$1.18 M(-43.6%)
May 2008
-
-$120.30 K(-941.3%)
-$2.09 M(-35.4%)
Feb 2008
-
$14.30 K(-101.2%)
-$3.24 M(-17.7%)
Nov 2007
-$3.93 M(+75.8%)
-$1.16 M(+39.8%)
-$3.93 M(+10.2%)
Aug 2007
-
-$827.20 K(-34.6%)
-$3.57 M(-0.9%)
May 2007
-
-$1.27 M(+85.7%)
-$3.60 M(+21.6%)
Feb 2007
-
-$681.50 K(-14.2%)
-$2.96 M(+32.4%)
Nov 2006
-$2.24 M(-222.7%)
-$794.10 K(-7.5%)
-$2.24 M(+205.7%)
Aug 2006
-
-$858.60 K(+37.2%)
-$731.20 K(-176.7%)
May 2006
-
-$625.90 K(-1552.2%)
$952.80 K(-34.5%)
Feb 2006
-
$43.10 K(-93.9%)
$1.46 M(-20.1%)
Nov 2005
$1.82 M(-52.5%)
$710.20 K(-14.0%)
$1.82 M(+18.4%)
Aug 2005
-
$825.40 K(-768.9%)
$1.54 M(-46.5%)
May 2005
-
-$123.40 K(-130.2%)
$2.87 M(-25.4%)
Feb 2005
-
$409.10 K(-4.3%)
$3.85 M(+0.3%)
Nov 2004
$3.84 M(-160.6%)
$427.30 K(-80.2%)
$3.84 M(-472.4%)
Aug 2004
-
$2.16 M(+153.0%)
-$1.03 M(-72.3%)
May 2004
-
$854.40 K(+115.5%)
-$3.72 M(-29.9%)
Feb 2004
-
$396.50 K(-108.9%)
-$5.32 M(-18.6%)
Nov 2003
-$6.33 M(+22.6%)
-$4.44 M(+735.1%)
-$6.54 M(+8.0%)
Aug 2003
-
-$532.10 K(-27.9%)
-$6.05 M(-2.4%)
May 2003
-
-$738.00 K(-10.2%)
-$6.20 M(+3.7%)
Feb 2003
-
-$821.80 K(-79.2%)
-$5.98 M(+15.8%)
Nov 2002
-$5.16 M(<-9900.0%)
-$3.96 M(+479.1%)
-$5.16 M(+269.3%)
Aug 2002
-
-$683.40 K(+32.7%)
-$1.40 M(+96.0%)
May 2002
-
-$514.90 K(>+9900.0%)
-$713.00 K(-307.8%)
Feb 2002
-
-$5000.00(-97.4%)
$343.10 K(+1185.0%)
Nov 2001
$26.70 K(-101.4%)
-$194.30 K(<-9900.0%)
$26.70 K(-110.9%)
Aug 2001
-
$1200.00(-99.8%)
-$245.40 K(-68.2%)
May 2001
-
$541.20 K(-268.4%)
-$772.40 K(-57.9%)
Feb 2001
-
-$321.40 K(-31.1%)
-$1.83 M(-0.8%)
Nov 2000
-$1.85 M(+105.3%)
-$466.40 K(-11.3%)
-$1.85 M(+187.3%)
Aug 2000
-
-$525.80 K(+1.1%)
-$643.20 K(-29.9%)
May 2000
-
-$519.90 K(+55.0%)
-$917.40 K(+31.5%)
Feb 2000
-
-$335.50 K(-145.5%)
-$697.50 K(-8.5%)
Nov 1999
-$900.00 K(-55.0%)
$738.00 K(-192.3%)
-$762.00 K(-61.9%)
Aug 1999
-
-$800.00 K(+166.7%)
-$2.00 M(+17.6%)
May 1999
-
-$300.00 K(-25.0%)
-$1.70 M(-10.5%)
Feb 1999
-
-$400.00 K(-20.0%)
-$1.90 M(+5.6%)
Nov 1998
-$2.00 M(+42.9%)
-$500.00 K(0.0%)
-$1.80 M(-5.3%)
Aug 1998
-
-$500.00 K(0.0%)
-$1.90 M(+11.8%)
May 1998
-
-$500.00 K(+66.7%)
-$1.70 M(+13.3%)
Feb 1998
-
-$300.00 K(-50.0%)
-$1.50 M(+25.0%)
Nov 1997
-$1.40 M(-255.6%)
-$600.00 K(+100.0%)
-$1.20 M(-36.8%)
Aug 1997
-
-$300.00 K(0.0%)
-$1.90 M(+111.1%)
May 1997
-
-$300.00 K(<-9900.0%)
-$900.00 K(-1000.0%)
Feb 1997
-
$0.00(-100.0%)
$100.00 K(-87.5%)
Nov 1996
$900.00 K
-$1.30 M(-285.7%)
$800.00 K(-61.9%)
Aug 1996
-
$700.00 K(0.0%)
$2.10 M(+50.0%)
May 1996
-
$700.00 K(0.0%)
$1.40 M(+100.0%)
Feb 1996
-
$700.00 K
$700.00 K

FAQ

  • What is Cryo-Cell International annual EBITDA?
  • What is the all time high annual EBITDA for Cryo-Cell International?
  • What is Cryo-Cell International annual EBITDA year-on-year change?
  • What is Cryo-Cell International quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cryo-Cell International?
  • What is Cryo-Cell International quarterly EBITDA year-on-year change?
  • What is Cryo-Cell International TTM EBITDA?
  • What is the all time high TTM EBITDA for Cryo-Cell International?
  • What is Cryo-Cell International TTM EBITDA year-on-year change?

What is Cryo-Cell International annual EBITDA?

The current annual EBITDA of CCEL is -$10.42 M

What is the all time high annual EBITDA for Cryo-Cell International?

Cryo-Cell International all-time high annual EBITDA is $7.22 M

What is Cryo-Cell International annual EBITDA year-on-year change?

Over the past year, CCEL annual EBITDA has changed by -$17.07 M (-256.65%)

What is Cryo-Cell International quarterly EBITDA?

The current quarterly EBITDA of CCEL is $2.25 M

What is the all time high quarterly EBITDA for Cryo-Cell International?

Cryo-Cell International all-time high quarterly EBITDA is $2.46 M

What is Cryo-Cell International quarterly EBITDA year-on-year change?

Over the past year, CCEL quarterly EBITDA has changed by +$18.00 M (+114.26%)

What is Cryo-Cell International TTM EBITDA?

The current TTM EBITDA of CCEL is -$10.30 M

What is the all time high TTM EBITDA for Cryo-Cell International?

Cryo-Cell International all-time high TTM EBITDA is $8.20 M

What is Cryo-Cell International TTM EBITDA year-on-year change?

Over the past year, CCEL TTM EBITDA has changed by +$113.00 K (+1.08%)